Globus Medical Reports Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
William Blair Downgrades Globus Medical (GMED) to Market Perform
November 9, 2016 7:30 AM ESTWilliam Blair downgraded Globus Medical (NYSE: GMED) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $22.33 yesterday.
... MoreOppenheimer Downgrades Globus Medical (GMED) to Perform
November 9, 2016 7:29 AM ESTOppenheimer downgraded Globus Medical (NYSE: GMED) from Outperform to Perform with a price target of $23.00 (from $29.00).
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $22.33 yesterday.
... MoreJMP Securities Downgrades Globus Medical (GMED) to Market Perform
November 9, 2016 6:46 AM ESTJMP Securities downgraded Globus Medical (NYSE: GMED) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $22.33 yesterday.
... MoreGlobus Medical (GMED) Reports In-Line Q3 EPS
November 8, 2016 4:22 PM ESTGlobus Medical (NYSE: GMED) reported Q3 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $135.7 million versus the consensus estimate of $139.25 million.
GUIDANCE:
Globus Medical sees FY2016 EPS of $1.20, versus the consensus of $1.20. Globus... More
